Overview
Leukoencephalopathy with bilateral anterior temporal lobe cysts (also known as van der Knaap disease or megalencephalic leukoencephalopathy with subcortical cysts, MLC) is a rare inherited neurological disorder characterized by progressive white matter deterioration in the brain. The condition is classified among the sphingolipidoses and related disorders (ICD-10: E75.2). It primarily affects the central nervous system, with hallmark features on brain MRI including diffuse swelling and signal abnormality of the cerebral white matter (leukoencephalopathy) along with characteristic cysts in the anterior temporal regions and often the frontoparietal regions. Patients typically present in the first year of life with macrocephaly (abnormally large head), which is often the earliest sign. Over time, affected individuals develop progressive motor deterioration, spasticity, cerebellar ataxia, and seizures. Cognitive decline occurs but is generally slower than motor deterioration, and many patients retain some cognitive abilities for years. The disease is caused by mutations in the MLC1 gene (most commonly) or the GLIALCAM (HEPACAM) gene. MLC1 mutations cause the classic autosomal recessive form (MLC1), while GLIALCAM mutations can cause either an autosomal recessive form (MLC2A, with a progressive course similar to MLC1) or an autosomal dominant form (MLC2B, which may show clinical improvement over time). The MLC1 and GLIALCAM proteins are involved in brain ion and water homeostasis, and their dysfunction leads to vacuolization of myelin and astrocyte swelling. There is currently no cure or disease-specific treatment for this condition. Management is supportive and symptomatic, including antiepileptic medications for seizure control, physical therapy to manage spasticity and motor difficulties, and occupational and speech therapy. The disease follows a slowly progressive course in most cases, with many patients eventually becoming wheelchair-dependent, though life expectancy can extend into adulthood.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for Leukoencephalopathy with bilateral anterior temporal lobe cysts.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Leukoencephalopathy with bilateral anterior temporal lobe cysts at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Leukoencephalopathy with bilateral anterior temporal lobe cysts.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Leukoencephalopathy with bilateral anterior temporal lobe cysts.
Community
No community posts yet. Be the first to share your experience with Leukoencephalopathy with bilateral anterior temporal lobe cysts.
Start the conversation →Latest news about Leukoencephalopathy with bilateral anterior temporal lobe cysts
No recent news articles for Leukoencephalopathy with bilateral anterior temporal lobe cysts.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Leukoencephalopathy with bilateral anterior temporal lobe cysts
What is Leukoencephalopathy with bilateral anterior temporal lobe cysts?
Leukoencephalopathy with bilateral anterior temporal lobe cysts (also known as van der Knaap disease or megalencephalic leukoencephalopathy with subcortical cysts, MLC) is a rare inherited neurological disorder characterized by progressive white matter deterioration in the brain. The condition is classified among the sphingolipidoses and related disorders (ICD-10: E75.2). It primarily affects the central nervous system, with hallmark features on brain MRI including diffuse swelling and signal abnormality of the cerebral white matter (leukoencephalopathy) along with characteristic cysts in the
At what age does Leukoencephalopathy with bilateral anterior temporal lobe cysts typically begin?
Typical onset of Leukoencephalopathy with bilateral anterior temporal lobe cysts is infantile. Age of onset can vary across affected individuals.